By Rady Ananda
Food Freedom News

The US Food & Drug Admin. just approved a drug made from genetically modified carrots to treat Gaucher, a rare disease found mostly among Ashkenazi Jews. Out of a global population of 6.8 billion, an estimated 600,000 to a million people carry the recessive gene for it, though not all are symptomatic.

The incidence of Gaucher is so rare, in fact, that to approve a GMO carrot for this purpose makes no sense, raising the specter of some unstated plan.

As expected when humans ingest active foreign DNA, one of the side effects of the FDA-approved drug, Elelyso®, is anaphylactic shock, among other allergic reactions.

Gaucher develops in offspring of parents who both carry and pass on a recessive gene that prevents development of an enzyme that allows “harmful substances to build up in the liver, spleen, bones, and bone marrow,” reports the A.D.A.M. Medical Encyclopedia. “The substances prevent cells and organs from working properly.”

The recessive gene only appears in 6-10 percent of Ashkenazi Jews, who number just over 10 million today.

Several rare genetic diseases are linked to Ashkenazi Jews, who account for 80 percent of all Jews, reports the Hebrew University of Jerusalem, “including Tay-Sachs, Gaucher disease, Bloom syndrome, Idiopathic torsion dystonia, Familial dysautonomia, Factor XI deficiency, and more. For many of these disorders in which a causative gene has been identified, a specific mutation was found to be the cause of most cases of the disease in Ashkenazi Jews.”

Dr. Mercola reacted with shock to the news, writing, “I don't even want to think about the potential ramifications of this decision. Many may not know this, but Monsanto, well-known as the leader in biotechnology and genetically engineered foods, is also invested in the medical industry.”

Approval of the drug was granted to Pfizer, the criminal pharmaceutical firm convicted in 2009 of defrauding Medicare and Medicaid recipients by selling them unneeded drugs for purposes not approved for Bextra.

Pfizer, along with its subsidiaries, Pharmacia & Upjohn Company, paid the largest healthcare fraud settlement in US history, to the tune of $2.3 billion. The Dept. of Justice [sic] allowed Pfizer to change its name to skirt federal laws requiring automatic exclusion from Medicare and Medicaid contracts as a result of the felony fraud convictions. No one went to jail and Pfizer paid a tiny portion of its profits from illegally dealing Bextra from 2001 thru 2005.

Monsanto, Pharmacia, Upjohn and Pfizer were all closely involved during that time.

In a recent study, Chinese researchers found small pieces of ribonucleic acid (RNA) in the blood and organs of humans who eat rice. They showed that this genetic material will bind to proteins in human liver cells and influence the uptake of cholesterol from the blood. The discovery, writes The Atlantic, “threatens to blast a major hole in Monsanto’s claim that ‘substantial equivalence’ means no safety testing is needed. But researchers found that DNA can code for microRNA, which can, in fact, be hazardous.”

Last year, biotech engineers began modifying rice with a human blood protein called human serum albumin (HAS).

The biotech industry asserts that the active DNA inserted into food and feed is destroyed in the gut of those who ingest GMO foods. However, another study showed that these toxins are found in the bloodstreams of 93% of pregnant women and their unborn babies. The wide-ranging harmful effects include sterility, lowered organ function, smaller brains, and may be linked to obesity, Type II diabetes, birth defects and spontaneous abortions.

That hazard is why the US government, the regulatory arm of the biotech industry, refuses to allow genetically modified foods to be labeled. Once GMO food is labeled, scientists can track the hazards caused by ingesting such food, which is precisely what Monsanto and the US government want to hide.

If you’d like to support the US campaign to label GMO foods, Dr. Mercola will match all donations made by May 26.